DK132123B - Analogifremgangsmåde til fremstilling af 11-oxygenerede pregnen-/17,16alfa-d/-1',3'-oxathiolaner. - Google Patents

Analogifremgangsmåde til fremstilling af 11-oxygenerede pregnen-/17,16alfa-d/-1',3'-oxathiolaner.

Info

Publication number
DK132123B
DK132123B DK688673AA DK688673A DK132123B DK 132123 B DK132123 B DK 132123B DK 688673A A DK688673A A DK 688673AA DK 688673 A DK688673 A DK 688673A DK 132123 B DK132123 B DK 132123B
Authority
DK
Denmark
Prior art keywords
oxathiolanes
16alpha
pregnene
oxygenated
preparation
Prior art date
Application number
DK688673AA
Other languages
English (en)
Other versions
DK132123C (da
Inventor
H Hofmeister
H Laurent
K Prezewowsky
R Wiechert
K Mengel
H Wendt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK132123B publication Critical patent/DK132123B/da
Application granted granted Critical
Publication of DK132123C publication Critical patent/DK132123C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/006Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a hydroxy group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0073Sulfur-containing hetero ring
    • C07J71/0089Sulfur-containing hetero ring containing sulfur and oxygen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK688673A 1972-12-22 1973-12-18 Analogifremgangsmade til fremstilling af 11-oxygenerede pregnen-(17,16alfa-d)-1',3'-oxathiolaner DK132123C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2264001A DE2264001C2 (de) 1972-12-22 1972-12-22 11β-Hydroxy-2',2'-dimethyl-1,4-pregnadieno[17,16α-d]-1',3'-oxathiolan-3,20-dion

Publications (2)

Publication Number Publication Date
DK132123B true DK132123B (da) 1975-10-27
DK132123C DK132123C (da) 1976-03-29

Family

ID=5865746

Family Applications (1)

Application Number Title Priority Date Filing Date
DK688673A DK132123C (da) 1972-12-22 1973-12-18 Analogifremgangsmade til fremstilling af 11-oxygenerede pregnen-(17,16alfa-d)-1',3'-oxathiolaner

Country Status (10)

Country Link
US (1) US3894004A (da)
JP (1) JPS4994659A (da)
BE (1) BE808984A (da)
CH (1) CH609066A5 (da)
DD (1) DD108530A5 (da)
DE (1) DE2264001C2 (da)
DK (1) DK132123C (da)
FR (1) FR2211258B1 (da)
GB (1) GB1457439A (da)
NL (1) NL7317655A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792758A (en) * 1995-12-08 1998-08-11 G. D. Searle & Co. Steroid nitrite ester derivatives useful as anti-inflammatory drugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3170920A (en) * 1962-08-10 1965-02-23 Shionogi & Co 3-oxo-16beta-mercapto-17beta-hydroxy-5alpha-androstane-16-17 acetonides and the process for the production thereof
US3770726A (en) * 1972-03-16 1973-11-06 Schering Ag Pregnano717,16alpha-d)-1',3'-oxathiolanes

Also Published As

Publication number Publication date
JPS4994659A (da) 1974-09-09
DD108530A5 (da) 1974-09-20
BE808984A (fr) 1974-06-21
DK132123C (da) 1976-03-29
GB1457439A (en) 1976-12-01
DE2264001C2 (de) 1982-08-26
NL7317655A (da) 1974-06-25
CH609066A5 (da) 1979-02-15
FR2211258B1 (da) 1976-09-03
FR2211258A1 (da) 1974-07-19
US3894004A (en) 1975-07-08
DE2264001A1 (de) 1974-07-04

Similar Documents

Publication Publication Date Title
DK135047B (da) Analogifremgangsmåde til fremstilling af 11,11-alkylidensteroider af estran- eller 19-norpregnanrækken.
DK134490B (da) Analogifremgangsmåde til fremstilling af 2,6-diaminonebularin-derivater.
DK139678B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin.
DK140406B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin.
DK132500B (da) Analogifremgangsmåde til fremstilling af 2beta, 16beta-diamino-5alfa-androstaner.
DK134604B (da) Fremgangsmåde til fremstilling af indenyl-3-acetoglucuronider.
DK137639B (da) Analogifremgangsmåde til fremstilling af 1-aminomethyl-2,2-diaryl-cyclopropancarboxamider.
DK130994B (da) Analogifremgangsmåde til fremstilling af 21-(beta-benzoylaminoisobutyryl)-16alfa,17alfa-(p-dimethylaminobenzyliden)-triamcinolon.
DK138645B (da) Analogifremgangsmåde til fremstilling af sulfamoylfenyl-imidazolidiner.
DK131575B (da) Analogifremgangsmåde til fremstilling af 2beta-hydroxy-3alfa-aminosteroider.
DK131855B (da) Fremgangsmåde til fremstilling af 3,4-dihydropyridoner.
DK129657B (da) Analogifremgangsmåde til fremstilling af 3-methylpyrazol-5-carboxamider.
DK135166B (da) Analogifremgangsmåde til fremstilling af 2-methyl-5-nitro-imidazoler.
DK132410B (da) Analogifremgangsmåde til fremstilling af 2-amino-4H-pyraner.
DK132221B (da) Fremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimider.
DK127778B (da) Fremgangsmåde til fremstilling af 3',4'-dideoxy-kenamycin B.
DK132329B (da) Fremgangsmåde til fremstilling af cardenolid-3,alfa-/2'-desoxy-glycosider/.
DK132032B (da) Analogifremgangsmåde til fremstilling af 15alfa,16alfa-methylen-4-pregnener.
DK134236B (da) Analogifremgangsmåde til fremstilling af 3-cycloalkoxy-16alfa-cyanopregn-5-en-20-oner.
DK130308B (da) Fremgangsmåde til fremstilling af 13β-alkylgona-4,9,11-triener.
DK139225B (da) Fremgangsmåde til fremstilling af morphanthridiner.
DK139677B (da) Fremgangsmåde til fremstilling af 7-benzoylindolin-2-oner.
DK132123B (da) Analogifremgangsmåde til fremstilling af 11-oxygenerede pregnen-/17,16alfa-d/-1',3'-oxathiolaner.
DK131037B (da) Analogifremgangsmåde til fremstilling af 15alfa,16alfa-methylen-4-østren-17beta-oler.
DK133812B (da) Fremgangsmåde til fremstilling af hydrohalogenider af 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorcytosin.